Yukin Therapeutics

Yukin Therapeutics specializes in the development of new molecules for the treatment of cancer.

Business Model:

Revenue: $0

Employees: 1-10

Detailed Yukin Therapeutics Information

Geographic Data

Yukin Therapeutics headquarters map

Address:

City: Biot

State: Provence-Alpes-Cote d&s;Azur

Zip:

Country: France

Financial Info

Stage:

series unknown

Raised Last:

$4M

Raised Total:

$4M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Yukin Therapeutics is a French biotechnology company. The company focuses on the development of new therapeutic molecules, entitled kinase inhibitors, specifically targeting a protein involved in the development of several types of cancer: the NIK protein (NF-κB inducing kinase). Yukin Therapeutics led studies that demonstrated proof of concept in animal models and is now actively seeking to identify a first drug candidate to launch a clinical trial in oncology.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
6/2019 Venture Round 2 $3.7M AdBio partners
Medicxi
AdBio partners
Medicxi
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research